Abstract:Seven undescribed sesquiterpenes, including three dimeric guaianolide sesquiterpenes artemongolides G-I (1-3) and four sesquiterpene lactones artemanomalide D-G (16-19), along with seventeen known compounds isoabsinthin (4), absinthin (5), 11-eptabsinthin (6), 11, 11'-bis-epiabsinthin (7), 10', 11'- epiabsinthin (8), anabsinthin (9), isoanabsinthin (10), absinthin D (11), anabsin (12), caruifolin D (13), gnapholide (14), caruifolin C (15), 1β(R),10β(S)-dihydroxy-3-oxo-11β (S)H-4,11(13)-guaien-6α(S),12-olide (20), 1α,6α,8α-trihydroxy-5α,7βH-guaia-3,10(14),11(13)-trien-12-oic acid (21), 1α,6α,8α-trihydroxy-5α,7βH-guaia-3,9,11(13)-trien-12-oic acid (22), argyinolide J (23), artabsinolide A (24) were isolated from the plant Artemisia mongolica. The structures were determined by interpreting NMR, HRESIMS and ECD data. The X-ray crystal structure of 4, 7 and 8 were reported for the first time. In the anti-vitiligo activity test, compounds 2, 7, 12, 23 and 24 demonstrated activity in promoting melanogenesis at a concentration of 50 μM in B16 cells, with 8-methoxypsoralan (8-MOP) as a positive control. Further research on the mechanism revealed that artemongolides H (2) enhance the expression of MITF and TRPs by upregulating p-Akt and p-GSK-3β, leading to an increase in β-catenin content in the cell cytoplasm. Subsequently, β-catenin translocates into the nucleus, resulting in melanogenesis. The results supported the regulation of melanogenesis by artemongolide H (2) through the Akt/GSK3β/β-catenin signaling pathway. The anti-inflammatory results demonstrated that compounds 4, 5, 6, 9 and 14 can inhibit the upregulation of IL-6 mRNA and CCL2 mRNA expression. Compound 12 specifically inhibited the upregulation of IL-6 mRNA expression. These compounds exhibited significant anti-inflammatory activities. The activity results revealed that these sesquiterpene compounds have the potential to become lead compounds for the treatment of vitiligo and inflammatory diseases.

Heterocyclic pseudoguaianolide oligomers and seco -pseudoguaianolide derivatives from the inflorescence of Ambrosia artemisiifolia

Dimeric guaianolides and sesquiterpenoids from Artemisia anomala.

Artemisians A-D, Diseco-guaianolide Involved Heterodimeric [4 + 2] Adducts from Artemisia argyi.

Artanomadimers A-F: Six new dimeric guaianolides from Artemisia anomala

[Guaianolides from Aerial Parts of Artemisia Myriantha].

Lactone ring-opening seco-guaianolide involved heterodimers linked via an ester bond from Artemisia argyi with NO inhibitory activity.

Guaiane-Type Sesquiterpene Lactone from Artemisia integrifolia

Unusual guaiane sesquiterpenoids from Artemisia rupestris

Sesquiterpenoids from Aerial Parts of Artemisia Myriantha

Sesquiterpenoids from the Inflorescence of Ambrosia artemisiifolia

Artemisianins A-D, new stereoisomers of seco-guaianolide involved heterodimeric [4+2] adducts from Artemisia argyi induce apoptosis via enhancement of endoplasmic reticulum stress.

Guaianolide Sesquiterpenes With Significant Antiproliferative Activities From the Leaves of Artemisia argyi

A New 1, 10-Secoguaianolide from the Aerial Parts of Artemisia Anomala

New Sesquiterpenoids from Artemisia Anomala

Guaianolides and unusual 3-oxa-guaianolides from Artemisia macrocephala

NO inhibitory guaianolide-derived terpenoids from Artemisia argyi.

Guaianolide sesquiterpenes and their activity from Artemisia mongolica

Chrysanolide A, an unprecedented sesquiterpenoid trimer from the flowers of Chrysanthemum indicum L

New guaiane-type sesquiterpenoid dimers from Artemisia atrovirens and their antihepatoma activity

Sesquiterpenoids from Hedyosmum Orientale

Cytotoxic Sesquiterpene Lactones from Artemisia Myriantha